Position in TMO
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,264,429
+$696,221 QoQ
Shares Held
2,522
+118.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,344
of 2,602 holders
Holding Since
Sep 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cypress Capital Group holds $2,864,633 across 4 Diagnostics & Research names. TMO ranks #1 (44.1% of the industry book) .
All Filings in TMO
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,264,429 | 2,522 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $568,208 | 1,156 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $669,844 | 1,156 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $561,168 | 1,157 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $479,253 | 1,182 | Shares | Defined | 2025-07-25 | |
| 2023-09-30 | $366,467 | 724 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $452,357 | 867 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $299,712 | 520 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $228,536 | 415 | Shares | Defined | 2023-02-14 | |
| 2022-03-31 | $408,139 | 691 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $250,882 | 376 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $295,948 | 518 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $235,083 | 466 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $309,882 | 679 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $367,500 | 789 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $248,134 | 562 | Shares | Sole | 2020-10-08 | |
| No filing history on record for this holder in this stock. | ||||||